June 4, 2021
Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
Company announcement – No. 36/ 2021 Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference Copenhagen, DK…
Pharmaceuticals, Biotechnology and Life Sciences
Company announcement – No. 36/ 2021 Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference Copenhagen, DK…
NEW HAVEN, Conn., June 03, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a pre-clinical,…
Basking Ridge, NJ, June 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE…
CAMBRIDGE, Mass., June 03, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a…
DUBLIN, Ireland and TREVOSE, Pa., June 03, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical…
– Without an NOC, Ruzurgi® is without a Marketing Authorization in Canada – Matter Remanded Back to Health Canada to…
Saint-Herblain (France), June 3, 2021 –Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines…
Men who received 177Lu-PSMA-617 plus best standard of care had a 38% reduction in risk of death (median OS benefit…
Joint stock company “Olainfarm”, unified registration number 40003007246, legal address: 5 Rūpnīcu Street 5, Olaine, LV 2114, hereinafter referred to…
NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…